Estrella Immunopharma (ESLA) Income Statement (2021 - 2026)
Income Statement report data from Mar 31, 2021 to Mar 31, 2026 for Estrella Immunopharma (ESLA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | ||||||||||||||||||||
Research And Development | 1.40M (+4566.67%) | 30K (-99.28%) | 4.15M (-10.94%) | 4.66M (+230.50%) | 1.41M (-50.18%) | 2.83M (-19.83%) | 3.53M (+11666.67%) | 30K (-62.50%) | 80K (-83.33%) | 480K | - | 2.62M (+0.38%) | 2.61M (0.00%) | 2.61M | - | - | - | - | - | - |
Selling General And Administrative | 890K (+50.85%) | 590K (-9.23%) | 650K (-26.14%) | 880K (+27.54%) | 690K (+25.45%) | 550K (+30.95%) | 420K (-4.55%) | 440K (-53.68%) | 950K (-31.65%) | 1.39M | - | 120K (-20.00%) | 150K (-46.43%) | 280K | - | - | - | - | - | - |
Operating Expenses | 2.29M (+275.41%) | 610K (-87.29%) | 4.80M (-13.36%) | 5.54M (+163.81%) | 2.10M (-37.87%) | 3.38M (-14.43%) | 3.95M (+740.43%) | 470K (-53.92%) | 1.02M (-45.45%) | 1.87M | - | 2.74M (-0.72%) | 2.76M (-4.50%) | 2.89M | - | - | - | - | - | - |
Operating Income | ||||||||||||||||||||
Operating Income | -2.29M (+275.41%) | -610.00K (-87.29%) | -4.80M (-13.36%) | -5.54M (+163.81%) | -2.10M (-37.87%) | -3.38M (-14.43%) | -3.95M (+740.43%) | -470.00K (-53.92%) | -1.02M (-45.45%) | -1.87M (+1000.00%) | -170.00K (-93.80%) | -2.74M (-0.72%) | -2.76M (-4.50%) | -2.89M (+588.10%) | -420.00K (+200.00%) | -140.00K (0.00%) | -140.00K (+27.27%) | -110.00K | - | - |
Ebit | -2.29M (+275.41%) | -610.00K (-87.29%) | -4.80M (-13.36%) | -5.54M (+163.81%) | -2.10M (-37.87%) | -3.38M (-14.43%) | -3.95M (+740.43%) | -470.00K (-53.92%) | -1.02M (-45.45%) | -1.87M (+1000.00%) | -170.00K (-93.80%) | -2.74M (-0.72%) | -2.76M (-4.50%) | -2.89M (+588.10%) | -420.00K (+200.00%) | -140.00K (0.00%) | -140.00K (+27.27%) | -110.00K | - | - |
EBITDA | -2.29M (+275.41%) | -610.00K (-87.29%) | -4.80M (-13.36%) | -5.54M (+163.81%) | -2.10M (-37.87%) | -3.38M (-14.43%) | -3.95M (+740.43%) | -470.00K (-53.92%) | -1.02M (-45.45%) | -1.87M (+3640.00%) | -50.00K (-98.16%) | -2.72M (-1.45%) | -2.76M (-4.50%) | -2.89M (+702.78%) | -360.00K (+157.14%) | -140.00K (0.00%) | -140.00K (+27.27%) | -110.00K | - | - |
Other Income / Expenses | ||||||||||||||||||||
Interest Income | - | - | - | - | - | - | - | - | - | - | - | 110K | - | - | - | - | - | - | - | - |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | 110K | - | - | - | - | - | - | - | - |
Net Income | ||||||||||||||||||||
Income Before Tax | -2.29M (+275.41%) | -610.00K (-87.29%) | -4.80M (-13.36%) | -5.54M (+163.81%) | -2.10M (-37.87%) | -3.38M (-14.43%) | -3.95M (+740.43%) | -470.00K | - | -1.87M (+3640.00%) | -50.00K (+25.00%) | -40.00K | - | -340.00K (-5.56%) | -360.00K (+157.14%) | -140.00K (0.00%) | -140.00K (+27.27%) | -110.00K | - | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | 20K (0.00%) | 20K | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -2.29M (+275.41%) | -610.00K (-87.29%) | -4.80M (-13.36%) | -5.54M (+163.81%) | -2.10M (-37.87%) | -3.38M (-14.43%) | -3.95M (+740.43%) | -470.00K (-53.92%) | -1.02M (-45.45%) | -1.87M (+2237.50%) | -80.00K (-97.08%) | -2.74M (-0.72%) | -2.76M (-4.50%) | -2.89M (+702.78%) | -360.00K (+157.14%) | -140.00K (0.00%) | -140.00K (+27.27%) | -110.00K | - | - |
Net Income | -2.29M (+275.41%) | -610.00K (-87.29%) | -4.80M (-13.36%) | -5.54M (+163.81%) | -2.10M (-37.87%) | -3.38M (-14.43%) | -3.95M (+740.43%) | -470.00K (-53.92%) | -1.02M (-45.45%) | -1.87M (+2237.50%) | -80.00K (-97.08%) | -2.74M (-0.72%) | -2.76M (-4.50%) | -2.89M (+702.78%) | -360.00K (+157.14%) | -140.00K (0.00%) | -140.00K (+27.27%) | -110.00K | - | - |